Veraxa Biotech Director Marc Gruninger Reports Acquisition of $9,982.66 in Common Shares
Bitget2026/10/29 21:18- Veraxa Biotech director Marc Gruninger purchased 10,000 ordinary shares.
- He bought 867 shares at $0.98 each and 9,133 shares at $1 each.
- His direct holdings totaled 10,000 ordinary shares following the purchases.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
The Bank of Japan keeps its benchmark interest rate unchanged at 1.25%, warns of increasing risks of inflation overshooting, and maintains a gradual rate hike stance.
The Bank of Japan stated that core inflation has reached a level consistent with its price target and is expected to remain around this level. Medium- and long-term inflation expectations are maintained at approximately 2%. The central bank also emphasized the need to pay special attention to the risk of inflation deviating upward and becoming a reality.
User growth hits record high in Q3, but revenue "loses steam": Citi maintains neutral rating on Pinterest (PINS.US)
Pinterest's Q3 revenue and profits fell short of expectations, with weak monetization in Europe dragging down guidance. Citi maintains a neutral rating with a target price of $27.
The Bank of Japan emphasizes maintaining the underlying inflation rate near its 2% target.
Crypto prices
More
